Dharani Sugars & Chemicals
In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹20 Cr, against −₹21 Cr a year earlier (compared with Jun 2025). Promoters held 61.55% of Dharani Sugars & Chemicals in Sep 2026, unchanged from Jun 2026.
Peer Comparison
Fast Moving Consumer Goods › Agricultural Food & other Products › Sugar
| ₹633.20 | 34.64 | 13,398 Cr | 2.92 | 0.55% | 9.15% | 11.80% | 6,444 Cr | 371 Cr | |
| ₹224.99 | 17.93 | 4,958 Cr | 1.48 | 1.21% | 8.04% | 11.91% | 6,275 Cr | 270 Cr | |
| ₹17.82 | 99.00 | 4,260 Cr | 4.46 | 0.00% | 3.31% | 1.93% | 5,353 Cr | 116 Cr | |
| ₹3,143.50 | 32.38 | 3,942 Cr | 2.06 | 0.40% | 7.73% | 8.78% | 1,716 Cr | 122 Cr | |
| ₹18.33 | — | 3,902 Cr | — | 0.00% | 29.60% | -16.88% | 9,409 Cr | -780 Cr | |
| ₹406.50 | 15.88 | 3,290 Cr | 1.01 | 1.46% | 7.28% | 9.59% | 3,636 Cr | 207 Cr | |
| ₹824.60 | 25.03 | 1,651 Cr | 1.47 | 1.23% | 5.10% | 10.35% | 2,764 Cr | 66 Cr | |
| Dharani Sugars & Chemicals (this company) | ₹8.65 | — | — | — | — | — | — | 2 Cr | -104 Cr |
| Median 8 companies | ₹315.75 | 28.71 | 3,942 Cr | 1.77 | 0.55% | 7.73% | 9.59% | 4,495 Cr | 119 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
3- Company has low interest coverage ratio.
- Contingent liabilities of Rs.347 Cr.
- Promoters have pledged 54.0% of their holding.
Technical Indicators
Oscillators
Neutral
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Expenses | 2 | 1 | 1 | 2 | 3 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 5 |
| Operating Profit | -2 | -1 | -1 | -2 | -3 | -5 | -5 | -8 | -5 | -4 | -5 | -7 | -4 |
| OPM % | — | — | — | -4975% | -7575% | -1904% | -2223% | -4500% | -2387% | -243% | -3082% | -2668% | -806% |
| Other Income | 0 | 0 | 120 | 36 | 1 | -8 | 0 | -1 | 0 | 0 | 0 | -22 | 0 |
| Interest | 0 | 0 | 0 | 6 | 6 | 7 | 8 | 20 | 10 | 10 | 10 | 10 | 11 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 |
| PBT | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 | -20 | -20 | -44 | -20 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 | -20 | -20 | -44 | -20 |
| EPS (₹) | -2.23 | -2.06 | 33.97 | 6.87 | -4.05 | -7.82 | -5.67 | -10.48 | -6.2 | -5.95 | -6.11 | -13.28 | -6.02 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 364 | 364 | 509 | 482 | 316 | 110 | 31 | 40 | 1 | 0 | 0 | 0 | 3 |
| Expenses | 374 | 324 | 435 | 482 | 353 | 154 | 49 | 57 | 10 | 7 | 22 | 24 | 23 |
| Operating Profit | -11 | 40 | 74 | 0 | -37 | -44 | -18 | -18 | -9 | -7 | -22 | -24 | -20 |
| OPM % | -2.9% | 11% | 15% | 0% | -12% | -40% | -59% | -45% | -1127% | -3561% | -2903% | -900% | -754% |
| Other Income | 18 | 9 | 8 | 17 | 4 | 35 | 6 | 1 | 0 | 156 | -7 | -20 | -22 |
| Interest | 66 | 68 | 75 | 79 | 75 | 2 | 2 | 0 | 0 | 6 | 42 | 39 | 40 |
| Depreciation | 21 | 23 | 23 | 23 | 23 | 22 | 23 | 23 | 22 | 22 | 22 | 22 | 22 |
| PBT | -81 | -43 | -16 | -85 | -131 | -33 | -38 | -40 | -31 | 121 | -93 | -105 | -104 |
| Tax % | -8% | -72% | 12% | 1% | 14% | -10% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -74 | -12 | -17 | -85 | -149 | -30 | -38 | -40 | -31 | 121 | -93 | -105 | -104 |
| EPS (₹) | -25.23 | -4.08 | -5.25 | -25.72 | -44.98 | -9 | -11.46 | -12.11 | -9.45 | 36.54 | -28.01 | -31.54 | -31.36 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 42 | 42 |
| Reserves | -11 | 158 | 141 | 57 | -92 | -122 | -160 | -200 | -230 | -109 | -205 | -304 |
| Borrowings | 588 | 611 | 620 | 559 | 518 | 512 | 536 | 533 | 539 | 419 | 489 | 539 |
| Other Liabilities | 184 | 185 | 165 | 208 | 236 | 180 | 158 | 169 | 176 | 150 | 146 | 173 |
| Total Liabilities | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 | 449 |
| Fixed Assets | 462 | 629 | 610 | 604 | 583 | 558 | 538 | 514 | 492 | 470 | 448 | 425 |
| CWIP | 13 | 16 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 24 | 26 | 29 | 17 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Other Assets | 310 | 313 | 305 | 224 | 95 | 30 | 15 | 7 | 11 | 8 | 9 | 9 |
| Total Assets | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 | 449 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 50 | 61 | 113 | 145 | 89 | 7 | -14 | -3 | -5 | 126 | 6 | 81 |
| Investing | -6 | -4 | -5 | -8 | 14 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| Financing | -39 | -65 | -108 | -138 | -104 | -9 | 18 | -3 | 6 | -127 | -6 | -83 |
| Net Cash Flow | 5 | -8 | 1 | -1 | -1 | -2 | 5 | -6 | 1 | 0 | 0 | 0 |
| Free Cash Flow | 44 | 57 | 108 | 146 | 91 | 7 | -13 | -3 | -5 | 126 | 6 | 83 |
| CFO/EBITDA | -473 | 155 | 152 | -72,590 | -241 | -16 | 74 | 16 | 59 | -1,916 | -28 | -335 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 55 | 40 | 35 | 49 | 57 | 60 | 42 | 2,008 | — | — | — |
| Inventory Days | 246 | 335 | 226 | 133 | 32 | 25 | 28 | 7 | — | — | — | — |
| Days Payable | 154 | 187 | 77 | 114 | 140 | 400 | 1,263 | 954 | — | — | — | — |
| Cash Conversion Cycle | 134 | 203 | 190 | 53 | -59 | -318 | -1,175 | -906 | 2,008 | — | — | — |
| Working Capital Days | -97 | -97 | -132 | -245 | -565 | -2,142 | -7,763 | -6,175 | -3,02,768 | — | — | — |
| ROCE % | -2% | 4% | 7% | -1% | -11% | -15% | -9% | -10% | -9% | -8% | -13% | -15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Dharani Sugars & Chemicals insights
64 extracted metrics + investor summaries across FY09–FY27.
Documents
Frequently Asked Questions about Dharani Sugars & Chemicals
What does Dharani Sugars & Chemicals Ltd do?
Where is Dharani Sugars & Chemicals Ltd (DHARSUGAR) listed?
Which sector does Dharani Sugars & Chemicals Ltd belong to?
Company Information
Incorporated in 1987, Dharani Sugars and Chemicals Ltd deals in manufacturing Sugar, Co-generation of Power and Alcohol including Ethanol[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DHARSUGAR.md for Dharani Sugars & Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.